
EVOMMUNE INC
EVMN · NYSE
Updated at 2026-10-15 04:31:45
- Today's High
- $5.96
- Today’s Low
- $5.64
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $6.09
- Previous Close
- $6.05
- Volume
- 384.15K
- Market Cap
- $209.4M
- P/E Ratio
- --
- EPS
- $-3.82
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 1891 PAGE MILL ROAD, PALO ALTO, CA, UNITED STATES, 94304
- Country
- US
- Listing Date
- 2025-11-06
- Fiscal Year End
- December
- Shares Outstanding
- 36.02M
- CIK
- --
- Website
- www.evommune.com
Evommune, Inc. is an innovative biotechnology company focused on developing cutting-edge therapeutics for immunological disorders, targeting significant unmet medical needs in this critical sector. With a promising pipeline and advanced research methodologies, Evommune is positioned to enhance immune response and improve patient outcomes. The company aims to establish a leading presence in the evolving immunotherapy market through its commitment to robust scientific practices and strategic partnerships. As it progresses through clinical trials, Evommune is striving to deliver transformative solutions that could redefine the standards of care in immunology, thereby significantly impacting patient quality of life.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$10M
Operating Expenses
2026-06-30
$34.89M
2026-03-31
$23.6M
2025-12-31
$29.71M
2025-09-30
$23.32M
Net Income
2026-06-30
-$32.24M
2026-03-31
-$21.67M
2025-12-31
-$28.27M
2025-09-30
-$12.47M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
-124.75%
Earnings Per Share
2026-06-30
$-0.89
2026-03-31
$-0.64
2025-12-31
$-1.43
2025-09-30
$-8.07
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$34.34M
2026-03-31
-$21.32M
2025-12-31
-$27.94M
2025-09-30
-$12.16M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $10M |
| Operating Expenses | $34.89M | $23.6M | $29.71M | $23.32M |
| Net Income | -$32.24M | -$21.67M | -$28.27M | -$12.47M |
| Net Profit Margin | -- | -- | -- | -124.75% |
| Earnings Per Share | $-0.89 | $-0.64 | $-1.43 | $-8.07 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$34.34M | -$21.32M | -$27.94M | -$12.16M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.